Department of Biochemistry and Molecular Medicine, School of Medicine, Universidad Autonoma de Nuevo Leon, Av, Madero ote, s/n esq, Eduardo Aguirre Pequeño, Col, Mitras Centro, CP 64460, Monterrey, Nuevo Leon, Mexico.
Infect Agent Cancer. 2013 Aug 30;8(1):31. doi: 10.1186/1750-9378-8-31.
Persistent infection with high-risk human papillomavirus (HPV) is a major risk factor for malignant lesions and cervical cancer. A widely studied element in the search for genetic factors influencing risk HPV infection diseases is allelic variation of the human leukocyte antigen (HLA) locus. The study was designed to search for HLA susceptibility alleles contributing to the persistence of HPV infection in Mexican women.
A total of 172 subjects were divided into three groups: 1) HPV-persistent patients; 2) HPV-cleared; and 3) HPV-reinfected patients. They were screened for HPV types using a polymerase chain reaction (PCR). PCR-sequence specific oligonucleotide probes (PCR-SSOP) was used for HLA DRB1 and DQB1 typing.
We observed that HLA-DQB10501 allele might be associated with susceptibility of reinfection with HPV (p = 0.01, OR = 4.9, CI 95% = 1.3 -18.7). Allele frequency of HLA-DRB114 was particularly reduced in patients with cancer when compared with the HPV-persistent group (p = 0.04), suggesting that this allele is a possible protective factor for the development of cervical cancer (OR = 2.98). HLA-DRB1*07 might be associated with viral clearance (p = 0.04).
Genetic markers for HPV infection susceptibility are different in each population, in Mexicans several HLA-DQB1 alleles might be associated with an enhanced risk for viral persistence. In contrast, DRB1*14, seems to confer protection against cervical cancer.
高危型人乳头瘤病毒(HPV)持续感染是导致恶性病变和宫颈癌的主要危险因素。在寻找影响 HPV 感染疾病风险的遗传因素的研究中,人类白细胞抗原(HLA)基因座的等位基因变异是一个备受关注的因素。本研究旨在寻找与 HPV 持续感染相关的 HLA 易感等位基因。
共纳入 172 名受试者,分为三组:1)HPV 持续感染患者;2)HPV 清除患者;3)HPV 再感染患者。采用聚合酶链反应(PCR)对 HPV 类型进行筛查。采用聚合酶链反应-序列特异性寡核苷酸探针(PCR-SSOP)对 HLA-DRB1 和 DQB1 进行分型。
我们观察到 HLA-DQB10501 等位基因可能与 HPV 再感染的易感性相关(p=0.01,OR=4.9,95%CI=1.3-18.7)。与 HPV 持续感染组相比,HLA-DRB114 等位基因在癌症患者中的频率明显降低(p=0.04),提示该等位基因可能是宫颈癌发生的保护性因素(OR=2.98)。HLA-DRB1*07 可能与病毒清除相关(p=0.04)。
HPV 感染易感性的遗传标志物在不同人群中存在差异,在墨西哥人群中,一些 HLA-DQB1 等位基因可能与病毒持续感染的风险增加相关。相比之下,DRB1*14 似乎对宫颈癌具有保护作用。